Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Mycoplasma genitalium G37, G-37

>MG_041 phosphocarrier protein HPr
MKKFQAVIKDPVGIHARPASILASEASKFKSELKLVAPSGVEGNIKSIIN
LMSLGIRHNDNITIKADGADEEEALAAIKACLEKNKVI
>MG_189 ABC transporter, permease protein
MFKNNLRFTSWINQHKFYQLDLSLKTRSIKQIVLTLVFKTLVLGFFGLIV
IFPFYLMVVVSFASDERALDTRTPILWPDSWNFDNFSRVLSDGKYLNAIV
VNTLVTVLSVLLTLFFTICMGYSFSLRKWKYKKLVWFFFLSVLILPESAL
LIGQYRIVIVANWNNPNSPLIVLGLIMPFVSSVFSGFMYRTSFEAIPSQL
KESALIDGCNGFNYFLKIALPMVKSTSWTVGILTAFSAWNSYLWPLLLLG
NRVDLNINLWVLQQGILDANSSDEQIRTLLNLKMSAAILAILPMFIIYFL
FHKRIMNAIKNRANTIKG
>MG_474 conserved hypothetical protein
MKVFKKLHNLNEILLLISIFFLVCIISLVGIGIIFDLIRKASLSAIRSDP
IFFNLRAVLIVLGVFAICFMIIQLVISIMIWKTINTACENIEPKFKKILH
WSCFLPFGLLQLYCYQKIKLVKQADNL
>MG_061 Mycoplasma MFS transporter
MENKSQKKVSDLKLITLWIIVIFGYLLFVVEWFVIDRISGKPTGILTQST
TTLPQYSGWLSSFFTENAGQIATSSTNWTITLLRAVGSILCGVVVLKFGY
RYAVLIMMGIMCVCFPFLIIGDPLNGHNQLTLLRPLSDSVKTQLSSLSSN
LQVGQLLGPVMINGKTMLADGTSVELIKGLDGNSIGTAASITGYALFIIF
RSTIAIGGTTLVVYTQPAIANLSSNRKKSILSNANLWGFNIGIAVVFTPF
LFEQVQQVASQYWVYIMTVMILVVFANLCLFLWFESKIDHIFPQKQTKEN
MSLTTQPKSIDILKNKTTWKLIGVYGIVLILIVNPLTPAWFSILQTVSPS
GSNGLISTGVYTTGLATLAIFWVIGYALGFVVFSPFNKTIYDKKRWMHFL
LTANIVVLLIIIMFAATLGIGSAAGFALISIFSFIGGAFAWSLSSSNLIL
PYEFKDYKKNELPILFGFCWGFGYIAYTLFDITQSVFLQAPVLIQGKGTS
ILPGVIVSIVFFLGLIALANLIVKFFPACWIKDGDQLVQEMTRKWKLNEW
QFVIANKQKNRYSELLK
>MG_129 conserved hypothetical protein
MKWLLWLGYIFSFGLLYLWIVKKSKQIAQQPNTKLVESTSIPFKVKDFVS
ACGGKENFVNIKTTPTQLIVTFKDVNSVSLTKLNALNIKGINKNQNQFRF
VLGNFVNELKKKIEDEQ
>MG_188 ABC transporter, permease protein
MFKWLLKHHNQPHSLQLGLLDQPLPFWKPFLLFLPALLTTILFTIIPFFL
SLQKGFSANSDLYDLSSQSFSLRTFQDLFSESNFVLGLRNSFLYSLISLP
FSIIIAIVIASAIVFVYKKLLRGFWQTVFFLPYVTSGVAISIAFVYIFDS
ASGILNTVFNVNTKWLDSGSRDTFNALWAILIFGVWKNLAFNVLIISTAM
LSVNPQLYKVASLDSANPVRQFFKITLPSIRPTLIFLTTLLILGGMQVFP
LALFENKPEEAVANGGNSILLYIFQQIQSGNTNLAGAATLVLFVLGVCYG
LVLRNGFYLIEWLQWKIKQLYVQKQLTLY
>MG_521 membrane protein, putative
MNGNKLVFLPKKSYHQLFNITFSAMMLALAIITSLISEFISIPFFSQLKL
TFDISVVFLVACAFFVSLGWSLTITLASALTSFFWNTNNVIGVLTVTLAN
LSTILFTRLYFCLFSKRRFCWIFVFLFTTLSNALLLTTLNGILITPLFWY
YFGYVQTPNFLIVAEQYNKNTDFHFFFFGINNYWLGIFCLYSFFNLVKFG
LVSCFGVPIMRSFQKFYWKRALAK
>MG_132 HIT domain protein
MEKNTTSSCIFCDIVQGSITSYKIGENEHAIAFLDAFPVADGHTLVIPKK
HAVDFSSTDQKELQAVSLLAKQIALKLKMTLKPSGLNYVSNEGAIAGQVV
FHFHLHIVPKYETGKGFGYNVNKTNKRSLEENYQLISESKN
>MG_187 ABC transporter, ATP-binding protein
MANNKSAIELKNIVVDFGESVAIDNINLSVEKHQLVSLLGPSGCGKTTTL
AVIAGLIKPTSGQVLFNGYDVTKKPPQERKLGLVFQNYALYPHMNVFENI
VFPLYSDNSWKQAVLEKNSVANHEINCLLLTSNGASVQEIDQLNKLFHDS
IEKPKQIQYQINDLNVSVFKNLNELTANLKLIPSKHQFAITNLNKQTLKQ
INELEAEFKTKWKLQKQTPIKSGVEHNAKLQAIKQHFSYEKQRLKKHYFK
TKVELKQTLVENLKLVKKAISEQTKLIKQSSDYTKLKQLKRLIKVEPNQL
KKQYKVFLNQLIKNYSLKTDKLTDTQLNEIEQIKTRIVSIKQFINKTALE
VANKLAITKILTKRPDKISGGQQQRVAIARAIVRRPKLLLMDEPLSNLDA
KLRVQTRQWIRQFQQELQITTVFVTHDQEEAMSISDVIVCMSTGKVQQIG
TPSELYLKPANEFVARFLGTPEMNIIECSVKNNQLFWNNHLLVTESFKLN
VEKLLVGFRYEQLVVTTNKSSLQAKLINIENLGKHLVATISLFDTTLSMR
LELNSHLKVGDSLNFIIKANNLHFFDIDTKQRIEI
>MG_452 membrane protein, putative
MLIIFKDLNLVKTNNCQIIGWWKQLSLPQKTFLSFIPLFLVTSAFVLTGI
VESLLTFGTIIEQIDKFTDQTNVMLLIYAVIYTFNPKSWLLKNQQFFLSA
LAYILFTFIGYNLILSIAGIAYKSTNPYKLTSSIFLHVIAPIAFFIASFI
KIKHEKDVNINMFFKSLLLFMIYPLIYGLYLVTIPYVRHYLFNGRPSTYT
IYGSITNTKNNPFAWLVVFAVLFIYFPLSYLAIYLLQLKLIKKAIQPQFN
LPFTLNKWKQK
>MG_128 inorganic polyphosphate/ATP-NAD kinase, probable
MKYKIFASTTPQTEPVLNKLRAVLKTWQAVENGYEYVFVLGGDGFFVSTL
ANYNCDSCKVVGINTGHIGFYTSFNGDDLDENFISKLTSFEFKKINLLEV
KTKNHSFLVLNELAVYTNTAYPINIFIDDNHWESYRGSGLLIGPRTGSTA
LAKSAKGAVIFPNVDVVQIIELNPLLHPNQITIQSPIILPMQTKVEFRIK
KAFKAEQFPNFYADGIKLDLKNEDTSISFQLVLSRSMFHASLKTKDFIDK
LKSTFIKQS
>MG_294 major facilitator superfamily protein, putative
MIVTTKKGFKKRLKDFSKQQILALIILGAIDVFVIAAPYYVKNVVPNLHL
YLGITEDEVATVTSIIGYVTLATQLPGGFLTNRFSSRKLLFLSAITTGAI
TFWLAANILTKNQQSHDALFIQYCVIWGLWGITSTLIFWTPLWKLASQQA
TKENQALGFGIQGAANGIWGLIFIFLIALIITSIFYPSGGSENADSKPFA
AYAFIIAIMLVITGFTVLFFVKEKPIEKQSQTTLVSFKRNLNQILVTLKN
WKLWLLSFFLMGMYVFQSTFAYYLLQMLQNAFLAPVVLVTVIGGIRTYAL
RSAVSVYLCRLADKCKSYILFLMICTVLGIVFVLAFILLGFVQTNSANIT
LITFSSILYIFTGILSWGMVTVRYNQIGEIDIGKNNYASSVGLLSFIGFS
TDGWLYTVTAEVGKKYTVAGQSNTSNTGYQIIAAICLSIALFGLICGSIV
FISNSMEIKRLNKASYRWRDLDNA
>MG_053 phosphoglucomutase/phosphomannomutase, putative
MDKLRLEVERWLNHPNVNWELKQQIKELNESEIQELFSLEKPLFGTAGVR
NKMAPGYHGMNVFSYAYLTQGYVKYIESINEPKRQLRFLVARDTRKNGGL
FLETVCDVITSMGHLAYVFDDNQPVSTPLVSHVIFKYGFSGGINITASHN
PKDDNGFKVYDHTGAQLLDTQTNQLLSDLPCVTSMLDLELQPNPKFVHTL
DNEKVYKNYFRELKKVLVINNNNFKDIKVVFSGLNGTSVCLMQRFLKYLG
YSNIISVEEQNWFDENFENAPNLNPEYKDTWILAQKYAKKNNAKLIIMAD
PDADRFAIAELNNNQWHYFSGNETGAITAYYKLNHKVFKSPYIVSTFVST
YLVNKIAKRYGAFVHRTNVGFKYIGQAINELSQTNELVVGFEEAIGLITS
DKLNREKDAYQAAALLLEIARHCKEQNITLLDFYKRILSEFGEYFNLTIS
HPFKATATDWKEEIKALFNQLINANLTEVAGFKVVKVHLDKQTNILEFGF
ENGWVKFRFSGTEPKLKFYFDLTNGTREALEKQAKKIYKFFVNLLKLNKA
>MG_320 membrane protein, putative
MINSTKGYIDQNGLAAKQFVQTKQLSVIRLTFMVAAFGIFFIFLVALTVQ
QLLSRSTLIDLASDFRTLSTIAVITSFVSLILYFVTAFKLRNPNTSLTWF
WALIITDVISYGITLGILLTLATTFSKQVNFEANDIVYAFLGASLVFGSV
WGLSALPSQKRRYQQTQTLFHILLWAFVISIVASLLSFILNFTVFASTTN
LLDRIIPGLSLIVGGIFSLISVYFVSLQIRNEQDLIKYYESEDYEMARRQ
SWRSALFFGAWLISSFMNLVYFILRIILITKNFSRV
>MG_524 conserved hypothetical protein
MGKEIEPIFDLVLLWFLFVPLLIYLFLAFFLFAFTKYIIWELIPFCYSTA
FTLIVLFLSGIIPMAWNSWIILLRFFLVLITLMLSFFLLNKMTNFFLIRS
KYAIIIAENLLKTGKSKTKNRQKLQQIQSDLERKKSAEIVFKIKKKKPK
>MG_407 eno, enolase
MGSSNLNINSKITDIFAYQVFDSRGVPTVACVVKLASGHVGEAMVPSGAS
TGEKEAIELRDNDPKNYFGKGVNEAVDNVNKVIAPKLIGLNAFDQLTVDQ
AMIKLDNTPNKAKLGANAILSVSLAVSKAAAKAQNSSLFQYISNKLIGLN
TTNFVLPVPMLNVINGGAHADNYIDFQEFMIMPLGAKKMHEALKMASETF
HALQNLLKKRGLNTNKGDEGGFAPNLKLAEDALDIMVEAIKLAGYKPWDD
IAIAIDVAASEFYDEDKKLYVFKKGIKANILNAKDWSLTSKEMIAYLEKL
TKKYPIISIEDGLSENDWEGMNQLTKTIGSHIQIVGDDTYCTNAELAKKG
VAQNTTNSILIKLNQIGSISETIQTIEVAKKANWSQVISHRSGETEDTTI
ADLAVAAQTGQIKTGSMSRSERIAKYNRLLYIEIELGDKGKYLGWNTFTN
IKPKNFNI
>MG_023 fba, fructose-1,6-bisphosphate aldolase, class II
MLVNFKLMLQKAKLGKYAIPHININNYEWAKAVLTAANQANSPIIVSVSE
GALKYMSGYSVVIPLVKGLIESLSVKVPVTLHLDHGSYDACIQALQAGFS
SVMFDGSHLPFEENFNKSKKLIEIAQKTNASVELEVGTIGGEEDGVIGQG
ELANVDECKQIASLKPDALAAGIGNIHGIYPKNWKGLNFPLIETISKITN
LPLVLHGGSGILENDVKKAISLGICKLNINTECQLAFAHEIRKYIESNKD
LDLNKKGYDPRKLLKEPTQAIVDTCLEKIDLCGSRNKA
>MG_062 fruA, PTS system, fructose-specific IIABC component
MFKNLLRPSLFFNWSQKTFKNKFSFLKQAANALQKQAVINDNNVAFEALK
KREEEITTGIITSLALPHLQSQSVIEPFVAVFKVKNLDWQSLDQKPVKLI
FLIGVLVDKTNLHLDFISNFSKLMLNETFASKVLNVTSYNGLIKLIDLFN
QQKVQDQPAVETKKEYDFVAVTACPTGIAHTFMAKEALEAFAKKHNLYVK
VETQGTDGIQNQLTSDDINNAKGVILACDRLIDFSRFYANKNVIEVSTTK
AIKKPDEVYELIKNQKGKQLANSAKPTNQTQLAESEGEFNFNNFHKRIYR
AILSGVSYMLPFVVFGGILIALSFLIDINNANNAGGNFGTINPVANWLNK
LGGISFSLIVPILSAYIAYALVSRQGLLPGFVVGLISSGQFLLNIVLTNG
TIEWLAPSQVSSGFFGAIFGGLLSACLIIVQQNYIYKKLPQSLQGIKNIL
FIPLFGTLFTAGLFWVINIPLIYLNYGLSLFLNIMNSPILAPLLGFVIGL
MMCFDLGGPINKAAYVFGVVSLQNQNAGTISMAAAMLSGMVPPLSIALAA
SIRKSCFDKQELPAAYACYLMGLSFISEGAIPFVVKKPKVMLTANLIAGA
ICGALTGAFALSIRAPHGGVFVFALLKTTLQGIEGATLQTGVGIGLALVC
LIISMIVGSSIIIGYDLIAKHNQRKQNLNS
>MG_063 fruK, 1-phosphofructokinase, putative
MTWLQNITKESKIWIVNYACAIDYYVDLNKQKNSVLIPGGKGINVAIVMK
SLGFDPTVITFLGQPTKNLFLELVKPYDLNIVSFISETKTRINLKLLKDE
KTTEINDLSPLITDANLTELLTFLKANVKNNDLVIINGRFKFEALEKVLN
LVFTLTENVVIDVDESKMLTLLNQSKPLVMKPNIDEFQTMINTFFHDQQS
LIAAIKKFHYCKLLLLSDGDKGAYLFDQNKLLFVSSITPKQVVSTTGAGD
TLLAVFLANLILKVDLKTALIKATNYASATISKLGVVDSKDKISVITPKS
YYL
>MG_301 gap, glyceraldehyde-3-phosphate dehydrogenase, type I
MAAKNRTIKVAINGFGRIGRLVFRSLLSKANVEVVAINDLTQPEVLAHLL
KYDSAHGELKRKITVKQNILQIDRKKVYVFSEKDPQNLPWDEHDIDVVIE
STGRFVSEEGASLHLKAGAKRVIISAPAKEKTIRTVVYNVNHKTISSDDK
IISAASCTTNCLAPLVHVLEKNFGIVYGTMLTVHAYTADQRLQDAPHNDL
RRARAAAVNIVPTTTGAAKAIGLVVPEANGKLNGMSLRVPVLTGSIVELS
VVLEKSPSVEQVNQAMKRFASASFKYCEDPIVSSDVVSSEYGSIFDSKLT
NIVEVDGMKLYKVYAWYDNESSYVHQLVRVVSYCAKL
>MG_033 glpF, glycerol uptake facilitator
MYFQNSTQLGWWFLAELIGTFILIIFGNGAVAQVNLKKMATSETKAKFLT
VALTWGIGVLFGVLTANAIFKGSGHLNPAISLFYAINGSIKSPTALIWPG
FVIGILAQFLGAMIAQTTLNFLFWKQLSSTDPQTVLAMHCTSPSVFNITR
NFLTEFIATLILIGGVVAASHFLHNNPNSVPPGFMGLWLVAGIIIAFGGA
TGSAINPARDLGTRIVFQLTPIKNKDANWKYSWIPVIAPLSAGLVLSIII
GFSPAPVL
>MG_430 gpmI, 2,3-bisphosphoglycerate-independent phosphoglycerate mutase
MHKKVLLAILDGYGISNAIYGNAVQNANTPMLDELINSYPCVLLDASGEA
VGLPMGQIGNSEVGHLNIGAGRVVYTGLSLINQHIKDRSFFANKAFLKTI
EHVEKNHSKIHLIGLFSNGGVHSHNEHLLALIELFSKHAKVVLHLFGDGR
DVAPCSLKQDLEKLMIFLKNYPNVVIGTIGGRYYGMDRDQRWDREMIAYK
ALLGVSKNKFNDPIGYIETQYQNQITDEFIYPAINANLNSDQFALNNNDG
VIFFNFRPDRARQMSHLIFNSNYYNYQPELKRKENLFFVTMMNYEGIVPS
EFAFPPQTIKNSLGEVIANNNLKQLRIAETEKYAHVTFFFDGGFEVNLSN
ETKTLIPSLKVATYDLAPEMSCKAITDALLEKLNNFDFTVLNFANPDMVG
HTGNYQACIKALEALDVQIKRIVDFCKANQITMFLTADHGNAEVMIDNNN
NPVTKHTINPVPFVCTDKNVNFNQTGILANIAPTILEYLNLSKPKEMTAK
SLLKNNN
>MG_215 pfk, 6-phosphofructokinase
MDKIAILTSGGDASGMNATIAYLTKYAIAKQLEVFYVKNGYYGLYHNHFI
TSKELDLTDFFFMGGTVIGSSRFKQFQDPSLRKQAVLNLKKRGINNLVVI
GGDGSYMGAKALSELGLNCFCLPGTIDNDVNSSEFTIGFWTALEAIRVNV
EAIYHTTKSHNRLAIIEVMGRDCSDLTIFGGLATNASFVVTSKNSLDLNG
FEKAVRKVLQFQNYCVVLVSENIYGKNGLPSLEMVKEHFENNAIKCNLVS
LGHTQRGFSPNSIELFQISLMAKHTIDLVVNNANSQVIGMKNNQAVNYDF
NTAFNLPKADRTKLLNQVNTAII
>MG_111 pgi, glucose-6-phosphate isomerase
MFMSDKLLTIDLSHVYGFDKEIIFKKYQKKVDQIHQDFLAHKLADGHMTG
WYDQPDQNHQFLLKTINQIDKKFKSLKVTDIVYVGIGGSFTGIKTVLDFL
KPKQRTGLKIHFVPDLSAFQAASVIKEIKNKSWALITTSKSGRTLEPALN
FRIFRNLLNKRYGNKHYQRVVVITDEKKGLLTKMASNHGYQKLVIDSNIG
GRFSTLSPAGLLLAKLFGHDPKAILKGTLQAKKDLQTTSLENNSAYLYAV
VRHWLYTTKKFKIEVCIAYHSLYEYLLLQHRQLFGESEGKNDKSLFPTFS
IFTVDLHSMGQLYQEGEKVFFETVIDVKNPLVNINLPPSDFDNDDELDFL
LDKSLNEISDVAIDSVIKAHYQANVSIIKLTLKEQSAFMFGYFYFWLSVA
TVMSGSLLGHNVFNQPGVEVYKKLMFEKLRSGH
>MG_300 pgk, phosphoglycerate kinase
MLNFKTLQAIDFQNKTVVLRSDFNVPMINGVISDSERILAGLDTIKFLVK
KNCKIVLLSHLSRIKSLEDKLNNKKSLKPVAELLQQLLPTVKVQFSCKNT
GAEVKQKVQALAFGEILLLENTRYCDVNDKGEIVKLESKNDPELAKFWAS
LGEIFVNDAFGTAHRKHASNAGIAKYVAKSCIGFLMEKELKNLSYLIQSP
QKPFVVVLGGAKVSDKLKVVENLLKLADNILIGGGMVNTFLKAKGKATAN
SLVEKELIDVAKQILDKDTHNKIVLAIDQVMGSEFKDQTGITLDVSDKIQ
EQYQSYMSLDVGSKTIALFESYLKTAKTIFWNGPLGVFEFTNFAKGTSKI
GEIIAKNKTAFSVIGGGDSAAAVKQMQLSDQFSFISTGGGASLALIGGEE
LVGISDIQKNS
>MG_069 ptsG, PTS system, glucose-specific IIABC component
MQISLVKIRNKFKQRNRGSFRQWVGKLSNGLMIPIAVLPLAGIFLGIGDA
ISSNSSGIVGVKFFGEFIKQGGNVVFANLPILFAVAIAITFSQDAGVAGF
SAFVFWATMNAFMSSLIIPVDANNTASGYNILYWKAVPQSAIASTLGLNS
LSTSVFGGIIVGALTAYLYNKFYAIRLPDVIGFFSGTRFVPIICMTIAIP
VALLLLMVWPGVSILLNLIGTGLGILGGRGYGANSLIFGYIERALIPFGV
HHAFYAPLWYTSAGGSLQEIANQQVWIRAPGSDYVTRVIGWEDFNTPGKW
VIPAALANGTSGMMNGATTTGQDSTSALSKYMSKESTNFLSWKELVDGLT
RKGNFDELAKNGLLDGSNKIWIGLNQSGILGKKVLLSDGKDYTITFKTFA
NTTPTFWSHGAHALLPISGTPSAITNGVTVNGTANSKTYNVSQFTVAVPS
LNPAQYSQGKFPFMLIGIPAAGLAMILAAPKGRRKEASSIIGSAAFTSFL
TGITEPFEFTFLFLAPWLFYGIHAVLAAVSFWLMNLLSANVGQTFSGSFI
DFILYGALPDGRGWLANSYLVPIIGIFLALIYFPTFYFLTIRFNLATPGR
GGKLITKKEYLAAKAAQKTDQTTNTNFNQTQIEAGMLLRAYGGSENIAEL
GACITKLRVTVKNPELVNETIIKDLGAAGVMRTTPTFFVAVFGTRAAVYK
SAMQDIIQGKVNWTELQKVLDKNDSTVEKPEIKPTPVLKVQDEIVILSPV
NGTLKPLTQVPDDTFKNRLVGDGIAILPSDGHFKAPGDVGVKTELAFPTG
HAFIFDVDGVKVMLHIGIDTVKINADKKPGEQLEVFDVKTKQGEYTKLKS
ESVVEVDLKKLKRKYDPITPFIVMQESLDNFKLVPIRQRGEIKVGQPLFK
LIYKDKKS
>MG_429 ptsI, phosphoenolpyruvate-protein phosphotransferase
MKKIIGIGVSDGIAVAKAFIIQTPQFDVKKYTNVKMTPTQAKKLLSSAFQ
KAKKDLEEIKTITVKNINQEAGMIFDAHIQILNDPTITEQLEQQLNKNIH
PVIAVDNVFQQTALMFSEMDDKYFKERASDILDLHQRLLSYLTGVKLNDL
IRIKSDVIIVANDLTPSQTATLNKKYVKGFLTESGGKTSHAAIMARSMEI
PAIVGLKNITSKVEDGKTVGINGRKGIVGFDFSSKDITQWKQEKELESNF
QNELKQYTNKLVKTLDGYEVIVASNIGNVKDMDLAVEYNTNGIGLFRTEF
LYMSSQDWPDESVQFEAYKTVLQKAKNDLVIIRTLDIGGDKKLNYFQFPH
EDNPFLGYRAIRLTLDKQAVFKTQLRALLRASDYGNLGIMFPMVATLDEL
VQVKQLLTKVQQEFNETKKFKLGIMIEIPSAALAADCLGKHVDFFSIGSN
DLIQYSFAADRMNKNVSYLYQPLNPALLRLIKLVVEGGKLNNVWTGMCGE
MASDQYAIPLLLGLGLTELSMSASSMFKARMVIAKITINECKSLVEKALK
LTSDSAVRKLVENFFKKKNIFI
>MG_216 pyk, pyruvate kinase
MIDHLKRTKIIATCGPALTKSLVSLKMLDDNEYAAIKKVAYANIEAIIKS
GVSVIRLNFSHGTHEEQQVRIKIVRDVAKAMNIPVSIMLDTNGPEIRIVE
TKKEGLKITKDSEVIINTMSKMIASDNQFAVSDASGKYNMVNDVNIGQKI
LVDDGKLTLVVTRVDKQHNQVICVAKNDHTVFTKKRLNLPNAQYSIPFLS
EKDLKDIDFGLSQGIDYIAASFVNTVADIKQLRDYLKLKNASGVKIIAKI
ESNHALNNIDKIIKASDGIMVARGDLGLEIPYYQVPYWQRYMIKACRFFN
KRSITATQMLDSLEKNIQPTRAEVTDVYFAVDRGNDATMLSGETASGLYP
LNAVAVMQKIDKQSETFFDYQYNVNYYLKNSTANKSRFWHNVVLPLTKKT
VPKRKLVNSAFKYDFIVYPTNNINRIYALSNARLAAAVIILTNNKRVYTG
HGVDYGIFCYLIDKNPNQLTKAELIELAWKAINHYQAYGDLEKLKQCLAV
YNETIINL
>MG_112 rpe, ribulose-phosphate 3-epimerase
MATKVVFSLLPLLNRFDKSLLESYFQDGLRLIHYDVMDQFVHNTAFKGEY
LDELKTIGFDVNVHLMVEQIIPQINFYLSQPNVKRISFHVEPFSFAKIKE
LIQLVKENGKEVGLAFKFTTNLQLYQPFFTTIDFITLMSVPPGKGGQAFN
EAVFTNLKIANHYNLKIEIDGGIKVNNIDQIKAFVDFIVMGSGFIKLEQW
QRQKLLQTI
>MG_396 rpiB, ribose 5-phosphate isomerase B
MSFNIFIASDHTGLTLKKIISEHLKTKQFNVVDLGPNYFDANDDYPDFAF
LVADKVKKNSDKDLGILICGTGVGVCMAANKVKGVLAALVVSEKTAALAR
QHDNANVLCLSSRFVTDSENIKIVDDFLKANFEGGRHQRRIDKIIRYEKE
TE
>MG_066 tkt, transketolase
MKYLYATQHLTLNAIKHAKGGHVGMAIGASPILFSLFTKHFHFDPDQPKW
INRDRFVLSAGHGSMALYSIFHFAGLISKQEILQHKHGQINTSSHPEYAP
NNFIDASTGPLGQGFGMAVGMVLAQKLLANEFKELSDKLFDHYTYVVVGD
GDLQEGVSYEVSQIAGLYKLNKLIVLHDSNRVQMDSEVKKVANENLKVRF
ENVGWNYIHTDDQLENIDQAIIKAKQSDKPTFIEVRTTIAKNTHLEDQYG
GHWFIPNEVDFQLFEKRTNTNFNFFNYPDSIYHWFKQTVIERQKQIKEDY
NNLLISLKDKPLFKKFTNWIDSDFQALYLNQLDEKKVAKKDSATRNYLKD
FLNQINNPNSNLYCLNADVSRSCFIKIGDDNLHENPCSRNIQIGIREFAM
ATIMNGMALHGGIKVMGGTFLAFADYSKPAIRLGALMNLPVFYVYTHDSY
QVGGDGPTHQPYDQLPMLRAIENVCVFRPCDEKETCAGFNYGLLSQDQTT
VLVLTRQPLKSIDNTDSLKTLKGGYILLDRKQPDLIIAASGSEVQLAIEF
EKVLTKQNVKVRILSVPNITLLLKQDEKYLKSLFDANSSLITIEASSSYE
WFCFKKYVKNHAHLGAFSFGESDDGDKVYQQKGFNLERLMKIFTSLRN
>MG_431 tpiA, triosephosphate isomerase
MRTRYLIGNWKTNKNLKDAVSFVEQFQQNKLNYNAKIGIAPVYVHLTEIK
KIISDSLLLFAQDANFIESGSYTGTVSFTQLQDIGVNNSIIGHSERRKYY
NETSAVINQKLFACLKASMQVVLCIGEALGQEISFLKTDLTNCLDTIDKS
LIKNLVIAYEPLWAIGTGKTATPEVANQTIKTIREYINDLYDENVANNIS
ILYGGSVDHNNIQKLAIMEQIDGFLVGKASLEIKNFLEMARVYA